Literature DB >> 26393018

Does the type of treatment supporter influence tuberculosis treatment outcomes in Zimbabwe?

N Mlilo1, C Sandy2, A D Harries3, A M V Kumar4, N Masuka5, B Nyathi1, M Edginton6, P Isaakidis7, M Manzi7, N Siziba2.   

Abstract

Zimbabwe National Tuberculosis Guidelines advise that direct observation of anti-tuberculosis treatment (DOT) can be provided by a family member/relative as a last resort. In 2011, in Nkayi District, of 763 registered tuberculosis (TB) patients, 59 (8%) received health facility-based DOT, 392 (51%) received DOT from a trained community worker and 306 (40%) from a family member/relative. There were no differences in TB treatment outcomes between the three DOT groups, apart from a higher frequency rate of 'no reported outcomes' for those receiving family-based DOT. Family members should be trained to use a suitable DOT support package.

Entities:  

Keywords:  DOT; Zimbabwe; operational research; treatment outcomes; treatment supporter; tuberculosis

Year:  2013        PMID： 26393018      PMCID： PMC4463109          DOI： 10.5588/pha.13.0002

Source DB:  PubMed          Journal:  Public Health Action        ISSN： 2220-8372


  5 in total

1.  Effectiveness of DOT for tuberculosis treatment outcomes: a prospective cohort study in Bangkok, Thailand.

Authors:  K Okanurak; D Kitayaporn; W Wanarangsikul; C Koompong
Journal:  Int J Tuberc Lung Dis       Date:  2007-07       Impact factor: 2.373

2.  Effectiveness of community-based directly observed treatment for tuberculosis in an urban setting in Tanzania: a randomised controlled trial.

Authors:  E Wandwalo; N Kapalata; S Egwaga; O Morkve
Journal:  Int J Tuberc Lung Dis       Date:  2004-10       Impact factor: 2.373

3.  Auditing the new decentralised oral treatment regimens in Malawi.

Authors:  T E Nyirenda; A D Harries; F K Gausi; K Ito; J R Kemp; B S Squire; P Godfrey-Faussett; F M Salaniponi
Journal:  Int J Tuberc Lung Dis       Date:  2004-09       Impact factor: 2.373

4.  Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport.

Authors:  Rony Zachariah; Anthony David Harries; Marcel Manzi; Patrick Gomani; Roger Teck; Mit Phillips; Peter Firmenich
Journal:  PLoS One       Date:  2006-12-27       Impact factor: 3.240

5.  Community-based DOTS and family member DOTS for TB control in Nepal: costs and cost-effectiveness.

Authors:  Tolib N Mirzoev; Sushil C Baral; Deepak K Karki; Andrew T Green; James N Newell
Journal:  Cost Eff Resour Alloc       Date:  2008-10-24
  5 in total
  4 in total

1.  Promoting operational research through fellowships: a case study from the South-East Asia Union Office.

Authors:  A M V Kumar; S Satyanarayana; S Dar Berger; S S Chadha; R J Singh; P Lal; J Tonsing; A D Harries
Journal:  Public Health Action       Date:  2015-03-21

2.  Family directly observed therapy for children with drug-resistant TB.

Authors:  M L Rekart; T Morshed; W K Mulanda; J Klieascikova; N Sitali; A Rajabzoda; S Avzamova; B Pirmahmadzoda; A Aung; M Sayfulloev; R Sleit; A Sinha
Journal:  Int J Tuberc Lung Dis       Date:  2022-08-01       Impact factor: 3.427

3.  Impact of Treatment Supporters on the Treatment Outcomes of Drug Resistant-Tuberculosis (DR-TB) Patients: A Retrospective Cohort Study.

Authors:  Om P Giri; Abhay Kumar; Vishal P Giri; Nishant Nikhil
Journal:  Cureus       Date:  2022-03-06

4.  Type of Treatment Supporters in Successful Completion of Tuberculosis Treatment: A Retrospective Cohort Study in Pakistan.

Authors:  Sana Hussain; Jamshed Hasnain; Zareen Hussain; Masroor Badshah; Hafeez Siddique; Christina Fiske; April Pettit
Journal:  Open Infect Dis J       Date:  2018-05-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.